Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
about
Physico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacyUltrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenograftsSelf-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin.Liver-targeting of interferon-alpha with tissue-specific domain antibodies.Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesRNAi for treating hepatitis B viral infection.Controlled delivery of antisense oligonucleotides: a brief review of current strategies.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.Beta-Sitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer.Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol.A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus.
P2860
Q28475692-AEBAE8C4-2019-4700-BA75-0434205D32C6Q28487464-331AE6D6-4783-45BB-B7A5-E7C289CDDA68Q33513270-F3CB90A3-FC8C-47E2-8AF4-3805FB72B1D9Q34603307-E79A6F38-1172-45E5-882D-17EA3EC1B5D7Q35090876-B3029710-DFE1-4CBA-8492-225227B869DFQ35605267-CDCA4A5E-59FE-406B-B1D8-C6CAE054D399Q36412870-7D5871B3-2800-4906-A66B-45E165C87602Q37529859-DF8A24C7-DEEE-47CF-9D5F-04E65F029DCCQ37572760-7EAC4A07-A3D2-4E00-9DCD-33C88B176A2EQ37735811-BBCEA7CE-C11F-4ADC-9E79-A9D9545D9D70Q37781788-3166D35A-A4F1-4016-9853-DB4C70931306Q38608961-F15BD442-8533-4BC4-901E-9A2427D3D1B4Q41747768-329A4158-6F42-47C0-840E-CBA073E43635Q41758629-C34C95F4-B0D4-4BBD-BFCD-30B36D4DC11B
P2860
Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@ast
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@en
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@nl
type
label
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@ast
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@en
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@nl
prefLabel
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@ast
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@en
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@nl
P2093
P1476
Mechanisms of co-modified live ...... nd antigens inhibition effect.
@en
P2093
Tsuneji Nagai
Xian Rong Qi
Yoshie Maitani
Yuan Zhang
P304
P356
10.1016/J.JCONREL.2006.11.006
P407
P577
2006-11-16T00:00:00Z